CervoMed Inc. files 8-K
- Filed on 2026-10-14
- Disclosed investor presentation info
- No financial statements included
CRVO
CervoMed Inc. SEC filings
Every EDGAR filing for CervoMed Inc. (CRVO), newest first, with AI summaries and stories.
- Ticker
- CRVO
- CIK
- 1053691
- Sector
- Biotech and pharma
- Latest filing
- 4d
Next: 10-Q expected ~Nov 10 (deadline Nov 16) ยท earnings expected ~Nov 12
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE CervoMed Inc. shares trial results
- Phase 2a trial showed reduced NfL levels in nfvPPA patients
- 24-week biomarker data to be presented in November 2026
- No approved treatments for nfvPPA in US or EU
ROUTINE8-KCervoMed Inc.CRVOLIVE CervoMed Inc. files Form 8-K
- Filed on 2026-10-09
- Disclosed investor presentation info
- No financial statements included
ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINESCHEDULE 13G/ACervoMed Inc.CRVOLIVE Ownership stake disclosure by RA CAPITAL MANAGEMENT, L.P. (amended)
RA CAPITAL MANAGEMENT, L.P., filed by
ROUTINESCHEDULE 13G/ACervoMed Inc.CRVOLIVE Ownership stake disclosure by CVI Investments, Inc. (amended)
CVI Investments, Inc., filed by
ROUTINESCHEDULE 13GCervoMed Inc.CRVOLIVE 2 13G filings
Ownership stake disclosure by Woodline Partners LP
Show all 2
- SCHEDULE 13GOwnership stake disclosure
- SCHEDULE 13GOwnership stake disclosure
Woodline Partners LP, filed by
ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINES-8CervoMed Inc.CRVOLIVE NOTABLE10-QCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINEEFFECTCervoMed Inc.CRVOLIVE ROUTINE424B3CervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINESCHEDULE 13G/ACervoMed Inc.CRVOLIVE Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
ROUTINES-3CervoMed Inc.CRVOLIVE ROUTINESCHEDULE 13GCervoMed Inc.CRVOLIVE Ownership stake disclosure by CVI Investments, Inc.
CVI Investments, Inc., filed by
ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE424B5CervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE NOTABLESCHEDULE 13D/ACervoMed Inc.CRVOLIVE Ownership stake disclosure by Joshua S Boger (amended)
Joshua S Boger, filed by
ROUTINE4CervoMed Inc.CRVOLIVE Joshua S Boger, insider filing for CRVO
Joshua S Boger, reporting
ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE4CervoMed Inc.CRVOLIVE 8 insider filings
Frank Zavrl, insider filing for CRVO
Show all 8
- 4Insider filing for CRVO
- 4Insider filing for CRVO
- 4Insider filing for CRVO
- 4Insider filing for CRVO
- 4Insider filing for CRVO
- 4Insider filing for CRVO
- 4Insider filing for CRVO
- 4Insider filing for CRVO
Frank Zavrl, reporting
ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE NOTABLE10-QCervoMed Inc.CRVOLIVE ROUTINESCHEDULE 13G/ACervoMed Inc.CRVOLIVE Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
ROUTINEARSCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINESCHEDULE 13G/ACervoMed Inc.CRVOLIVE Ownership stake disclosure by AWM Investment Company, Inc. (amended)
AWM Investment Company, Inc., filed by
ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE NOTABLE10-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE ROUTINE8-KCervoMed Inc.CRVOLIVE